Northern Trust Corp Acquires 17,748 Shares of LeMaitre Vascular, Inc. $LMAT

Key Points

• Northern Trust Corp increased its holdings in LeMaitre Vascular by 5.4%, now owning 345,563 shares valued at approximately $28.99 million.
• LeMaitre Vascular reported a quarterly earnings per share of $0.60, exceeding analysts' expectations of $0.57, alongside a revenue increase of 15% year-over-year.
• The company announced a quarterly dividend of $0.20, resulting in an annualized dividend of $0.80 with a yield of 0.8%.

Northern Trust Corp grew its stake in shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT - Free Report) by 5.4% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 345,563 shares of the medical instruments supplier's stock after purchasing an additional 17,748 shares during the quarter. Northern Trust Corp owned approximately 1.53% of LeMaitre Vascular worth $28,993,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently made changes to their positions in LMAT. Algert Global LLC lifted its position in LeMaitre Vascular by 111.5% during the 1st quarter. Algert Global LLC now owns 7,454 shares of the medical instruments supplier's stock valued at $625,000 after purchasing an additional 3,930 shares during the period. Nations Financial Group Inc. IA ADV raised its stake in LeMaitre Vascular by 5.0% during the 1st quarter. Nations Financial Group Inc. IA ADV now owns 24,659 shares of the medical instruments supplier's stock worth $2,069,000 after buying an additional 1,167 shares during the period. American Century Companies Inc. bought a new stake in LeMaitre Vascular during the 1st quarter worth approximately $857,000. Russell Investments Group Ltd. increased its position in LeMaitre Vascular by 11.6% in the first quarter. Russell Investments Group Ltd. now owns 264,261 shares of the medical instruments supplier's stock worth $22,172,000 after buying an additional 27,470 shares during the last quarter. Finally, HighTower Advisors LLC grew its holdings in shares of LeMaitre Vascular by 4.2% during the first quarter. HighTower Advisors LLC now owns 5,920 shares of the medical instruments supplier's stock worth $497,000 after purchasing an additional 237 shares in the last quarter. 84.64% of the stock is currently owned by institutional investors and hedge funds.

LeMaitre Vascular Price Performance

Shares of NASDAQ LMAT traded up $0.69 during trading hours on Friday, reaching $97.76. 19,535 shares of the stock traded hands, compared to its average volume of 189,357. The company has a quick ratio of 11.74, a current ratio of 13.96 and a debt-to-equity ratio of 0.46. LeMaitre Vascular, Inc. has a 52-week low of $71.42 and a 52-week high of $109.58. The company's 50-day simple moving average is $88.34 and its two-hundred day simple moving average is $86.34. The company has a market capitalization of $2.21 billion, a P/E ratio of 47.30, a price-to-earnings-growth ratio of 2.43 and a beta of 0.79.

LeMaitre Vascular (NASDAQ:LMAT - Get Free Report) last issued its earnings results on Tuesday, August 5th. The medical instruments supplier reported $0.60 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.57 by $0.03. The firm had revenue of $63.15 million for the quarter, compared to the consensus estimate of $62.48 million. LeMaitre Vascular had a net margin of 20.08% and a return on equity of 13.67%. The business's revenue was up 15.0% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.52 earnings per share. LeMaitre Vascular has set its Q3 2025 guidance at 0.540-0.590 EPS. FY 2025 guidance at 2.230-2.370 EPS. Equities research analysts forecast that LeMaitre Vascular, Inc. will post 1.94 EPS for the current year.

LeMaitre Vascular Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Thursday, September 4th. Investors of record on Thursday, August 21st were issued a $0.20 dividend. The ex-dividend date of this dividend was Thursday, August 21st. This represents a $0.80 dividend on an annualized basis and a yield of 0.8%. LeMaitre Vascular's dividend payout ratio is presently 38.83%.

Insider Buying and Selling at LeMaitre Vascular

In related news, CEO George W. Lemaitre sold 100,000 shares of the stock in a transaction that occurred on Wednesday, August 6th. The stock was sold at an average price of $93.51, for a total value of $9,351,000.00. Following the completion of the transaction, the chief executive officer directly owned 1,727,003 shares in the company, valued at approximately $161,492,050.53. This represents a 5.47% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director David B. Roberts sold 10,815 shares of the firm's stock in a transaction dated Monday, August 11th. The stock was sold at an average price of $92.39, for a total value of $999,197.85. Following the sale, the director directly owned 17,976 shares in the company, valued at $1,660,802.64. This trade represents a 37.56% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 120,815 shares of company stock worth $11,280,206 in the last quarter. Insiders own 9.50% of the company's stock.

Analyst Upgrades and Downgrades

LMAT has been the topic of several analyst reports. Barrington Research raised LeMaitre Vascular from a "market perform" rating to an "outperform" rating and set a $95.00 target price on the stock in a report on Wednesday, August 6th. Cantor Fitzgerald boosted their target price on shares of LeMaitre Vascular from $92.00 to $95.00 and gave the stock a "neutral" rating in a research report on Wednesday, August 6th. Two investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company's stock. Based on data from MarketBeat, the company presently has a consensus rating of "Hold" and an average target price of $97.60.

LeMaitre Vascular Company Profile

LeMaitre Vascular, Inc develops, manufactures, and markets medical devices and implants used in the field of vascular surgery worldwide. It offers human cadaver tissue cryopreservation services; angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature.